Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-26 @ 2:32 AM
Study NCT ID:
NCT03428802
Status:
RECRUITING
Last Update Posted:
2022-11-18
First Post:
2018-02-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
Sponsor:
Rutgers, The State University of New Jersey
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-02
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-05
First Submit QC Date:
None
Study First Post Date:
2018-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-16
Last Update Post Date:
2022-11-18
Last Update Post Date Type:
ACTUAL